Original language | English (US) |
---|---|
Pages (from-to) | 656-661 |
Number of pages | 6 |
Journal | Leukemia |
Volume | 34 |
Issue number | 2 |
DOIs | |
State | Published - Feb 1 2020 |
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Clinicopathologic characteristics, prognostication and treatment outcomes for myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U) : Mayo Clinic-Moffitt Cancer Center study of 135 consecutive patients. / Mangaonkar, Abhishek A.; Swoboda, David M.; Coltro, Giacomo et al.
In: Leukemia, Vol. 34, No. 2, 01.02.2020, p. 656-661.Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Clinicopathologic characteristics, prognostication and treatment outcomes for myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U)
T2 - Mayo Clinic-Moffitt Cancer Center study of 135 consecutive patients
AU - Mangaonkar, Abhishek A.
AU - Swoboda, David M.
AU - Coltro, Giacomo
AU - Lasho, Terra L.
AU - Novotny, Paul J.
AU - Pophali, Prateek
AU - Carr, Ryan M.
AU - Binder, Moritz
AU - Finke, Christy M.
AU - Gangat, Naseema
AU - Al-Kali, Aref
AU - Begna, Kebede H.
AU - Reichard, Kaaren K.
AU - Ketterling, Rhett P.
AU - Al Ali, Najla H.
AU - Vafaii, Pardis
AU - Zhang, Ling
AU - Padron, Eric
AU - Talati, Chetasi
AU - Patnaik, Mrinal M.
N1 - Funding Information: Acknowledgements This publication was supported by Grant#UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), however, it does not necessarily represent official views of NIH.
PY - 2020/2/1
Y1 - 2020/2/1
UR - http://www.scopus.com/inward/record.url?scp=85073984841&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85073984841&partnerID=8YFLogxK
U2 - 10.1038/s41375-019-0574-x
DO - 10.1038/s41375-019-0574-x
M3 - Letter
C2 - 31511613
AN - SCOPUS:85073984841
SN - 0887-6924
VL - 34
SP - 656
EP - 661
JO - Leukemia
JF - Leukemia
IS - 2
ER -